Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16014 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Maeve E Wickham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Databases, Factual, Drug Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Aims
Medication non‐adherence is a type of adverse drug event that can lead to untreated and exacerbated chronic illness, and that drives healthcare utilization. Research using medication claims data has attempted to identify instances of medication non‐adherence using the proportion of days covered or by examining gaps between medication refills. We sought to validate these measures compared to a gold standard diagnosis of non‐adherence made in hospital.
Methods
This was a retrospective analysis of adverse drug events diagnosed during three prospective cohorts in British Columbia between 2008 and 2015 ( n = 976). We linked prospectively identified adverse drug events to medication claims data to examine the sensitivity and specificity of typical non‐adherence measures.
Results
The sensitivity of the non‐adherence measures ranged from 22.4% to 37.5%, with a proportion of days covered threshold of 95% performing the best; the non‐persistence measures had sensitivities ranging from 10.4% to 58.3%. While a 7‐day gap was most sensitive, it classified 61.2% of the sample as non‐adherent, whereas only 19.6% were diagnosed as such in hospital.
Conclusions
The methods used to identify non‐adherence in administrative databases are not accurate when compared to a gold standard diagnosis by healthcare providers. Research that has relied on administrative data to identify non‐adherent patients both underestimates the magnitude of the problem and may label patients as non‐adherent who were in fact adherent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
- Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
- Emergency Department, Vancouver General Hospital, Vancouver, BC, Canada.
ORCID-Profile: Corinne M Hohl
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Wickham, M. E., McGrail, K. M., Law, M. R., Cragg, A., & Hohl, C. M. (2024). Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16014
Vancouver
Wickham ME, McGrail KM, Law MR, Cragg A, Hohl CM. Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16014
BibTeX
@article{Wickham2024,
author = {Wickham, Maeve E and McGrail, Kimberlyn M and Law, Michael R and Cragg, Amber and Hohl, Corinne M},
title = {Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16014}
}
EUVIMED